STERIS (STE) Stock Forecast & Price Target

$221.80

-2.59 (-1.15%)

(As of 10/31/2024 ET)

STERIS - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 6 Analyst Ratings

Sell
0

Hold
2

Buy
4

Based on 6 Wall Street analysts who have issued ratings for STERIS in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 2 have given a hold rating, and 4 have given a buy rating for STE.

Consensus Price Target

$253.00
14.07% Upside

According to the 6 analysts' twelve-month price targets for STERIS, the average price target is $253.00. The highest price target for STE is $265.00, while the lowest price target for STE is $215.00. The average price target represents a forecasted upside of 14.07% from the current price of $221.80.

Get the Latest News and Ratings for STE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for STERIS and its competitors.

STE Analyst Ratings Over Time

Type	Current Forecast 11/1/23 to 10/31/24	1 Month Ago 10/2/23 to 10/1/24	3 Months Ago 8/3/23 to 8/2/24	1 Year Ago 11/1/22 to 11/1/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	2 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$253.00	$246.00	$241.60	$242.60
Forecasted Upside	14.07% Upside	4.33% Upside	-0.41% Downside	13.97% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

$5k to $1.3m in just 3 trades (Ad)

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

STE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

STE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

STERIS Stock vs. The Competition

Type	STERIS	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	13.35% Upside	15,895.47% Upside	10.27% Upside
News Sentiment Rating	Positive News See Recent STE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/24/2024	Piper Sandler 2 of 5 stars	J. Bednar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $260.00	+17.57%
9/3/2024	KeyCorp 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$255.00 ➝ $265.00	+9.11%
8/8/2024	Needham & Company LLC 2 of 5 stars		Reiterated Rating	Hold
8/7/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$265.00 ➝ $265.00	+13.48%
8/7/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$260.00 ➝ $260.00	+11.66%
12/4/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$225.00 ➝ $215.00	+5.65%
Get the Latest News and Ratings for STE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 08:40 PM ET.

Should I Buy STERIS Stock? STE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 25, 2024. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com.

STERIS
Bull Case

Here are some ways that investors could benefit from investing in STERIS plc:

STERIS plc provides infection prevention products and services worldwide, catering to a growing global demand for healthcare solutions.
Recent developments show that STERIS plc is focused on creating a healthier and safer world through innovative healthcare and life science solutions.
Current stock price of STERIS plc is favorable for investors, offering a potential entry point for those looking to invest.
STERIS plc operates through multiple segments, diversifying its revenue streams and potentially reducing risk for investors.
The company's commitment to innovation and global presence positions it well for future growth opportunities in the healthcare industry.

STERIS
Bear Case

Investors should be bearish about investing in STERIS plc for these reasons:

Stewart & Wight plc, a property investment company, may not align with the investment goals of those looking for exposure to healthcare and life science sectors.
Ster Peak Mining Ltd., an exploration stage junior mining company, is not directly related to the healthcare industry, potentially diverting attention from STERIS plc.

STE Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for STERIS is $253.00, with a high forecast of $265.00 and a low forecast of $215.00.
: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STE shares.
: According to analysts, STERIS's stock has a predicted upside of 14.07% based on their 12-month stock forecasts.
: Over the previous 90 days, STERIS's stock had 1 upgrade by analysts.
: STERIS has been rated by research analysts at JMP Securities, KeyCorp, Needham & Company LLC, Piper Sandler, and Stephens in the past 90 days.
: Analysts like STERIS less than other "medical" companies. The consensus rating score for STERIS is 2.67 while the average consensus rating score for "medical" companies is 2.79. Learn more on how STE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

This page (NYSE:STE) was last updated on 10/31/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Stock Forecast & Price Target